Journal of the National Comprehensive Cancer Network · 2018 · 242 citations · 54 references
MedicineOncologyPharmacotherapyCancer PreventionHematologic OncologyOncology PharmacotherapyAnticoagulant TherapyAnticoagulation TherapyThromboembolic DiseaseThrombosisThrombosis PreventionVenous ThromboembolismAnticoagulation In Hematologic MalignancyCancer-associated Deep Vein ThrombosisCancer-associated Pulmonary EmbolismCancer-associated Thrombosis PreventionTherapeutic AnticoagulationThromboprophylaxis In Cancer PatientsVenous Thromboembolism AssessmentVenous Thromboembolism Prophylaxis Policies
Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.
54
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Sam Schulman, Clive Kearon, Ajay K. Kakkar et al. · New England Journal of Medicine · 2009 · 2.6K citations · Full text
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen et al. · New England Journal of Medicine · 2013 · 2.3K citations · Full text